By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cara Therapeutics, Inc. 

One Parrott Drive

Shelton  Connecticut  06484  U.S.A.
Phone: 203-567-1500 Fax: 203-567-1510


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Cara Therapeutics, Inc. (CARA) Issued Additional U.S. Patent Covering The Expanded Use Of Kappa Opioid Receptor Agonist CR845 And Analogs For The Treatment And Prevention Of Pain-Related Conditions 2/10/2015 7:50:02 AM
Cara Therapeutics, Inc. (CARA) To Webcast Presentation At 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/2/2015 10:11:50 AM
Cara Therapeutics, Inc. (CARA) Announces Addition To The NASDAQ Biotechnology Index 12/18/2014 8:07:37 AM
Cara Therapeutics, Inc. (CARA) Reports Positive Top-Line Data From Phase 1b Trial Of I.V. CR845 In Dialysis Patients 12/17/2014 7:26:13 AM
Enteris Biopharma's Formulation Technology Enables Oral Delivery Of Cara Therapeutics, Inc. (CARA)' CR845 Peptide For Acute And Chronic Pain In Phase 1a / 1b Trial 12/9/2014 8:35:48 AM
Cara Therapeutics, Inc. (CARA) Announces Appointment Of Joseph Stauffer, D.O., As Chief Medical Officer 12/5/2014 9:53:55 AM
Cara Therapeutics, Inc. (CARA) Announces Positive Top-Line Results From Phase 1a / 1b Trial Of Tablet Formulation Of Oral CR845 For The Treatment Of Acute And Chronic Pain 12/3/2014 11:07:34 AM
Cara Therapeutics, Inc. (CARA) To Webcast Presentation At 26th Annual Piper Jaffray Healthcare Conference 12/1/2014 4:19:49 PM
Cara Therapeutics, Inc. (CARA) To Webcast Presentation At 2014 Stifel Healthcare Conference 11/12/2014 8:21:11 AM
Cara Therapeutics, Inc. (CARA) Reports Third Quarter 2014 Financial Results 11/11/2014 7:56:22 AM
12345
//-->